Cromatina / Epigenética
Los inhibidores de cromatina/epigenética son compuestos que modulan la estructura y función de la cromatina o interfieren con modificaciones epigenéticas, como la metilación del ADN y la modificación de histonas. Estos inhibidores son herramientas esenciales para estudiar la regulación de la expresión génica y el papel de la epigenética en enfermedades como el cáncer, los trastornos neurológicos y las anomalías del desarrollo. Al dirigirse a los procesos epigenéticos, estos inhibidores pueden alterar los patrones de expresión génica y ofrecer nuevas vías terapéuticas. En CymitQuimica, ofrecemos una amplia selección de inhibidores de cromatina/epigenética de alta calidad para apoyar su investigación en biología molecular, genética y epigenética.
Subcategorías de "Cromatina / Epigenética"
Se han encontrado 2235 productos de "Cromatina / Epigenética"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
JAK3-IN-9
CAS:<p>JAK3-IN-9, potent JAK3 inhibitor, IC50 of 1.7 nM, highly selective, low toxicity, orally bioavailable, shows anti-arthritis activity.</p>Fórmula:C17H23N5O4SForma y color:SolidPeso molecular:393.46PARP-2/1-IN-2
CAS:<p>PARP-2/1-IN-2, Veliparib's enantiomer, inhibits PARP-1/2 (Ki: 5/2 nM) with 3 nM EC50 in cell assay.</p>Fórmula:C13H16N4OForma y color:SolidPeso molecular:244.29ZLD10A
CAS:<p>ZLD10A is a highly potent and selective small molecule inhibitor of EZH2.</p>Fórmula:C37H48N4O4Pureza:98%Forma y color:SolidPeso molecular:612.8WAY-260022
CAS:<p>WAY-260022 is the norepinephrine transporter inhibitor.</p>Fórmula:C21H31F3N2O2Pureza:97.61% - 99.41%Forma y color:SolidPeso molecular:400.48LB-205
CAS:<p>LB-205 is a Zn 2+ dependent pan-inhibitor of class I and class II HDACs. It also has a long half-life in vivo.</p>Fórmula:C18H21N3O2SForma y color:SolidPeso molecular:343.44CBP/p300-IN-10
CAS:<p>CBP/p300-IN-10, potent EP300/CREBBP inhibitor; IC50: 26 nM/39 nM. Potential for cancer research.</p>Fórmula:C25H24F5N5O3Forma y color:SolidPeso molecular:537.48INCB16562
CAS:<p>INCB16562: oral JAK1/2 inhibitor, halts IL-6/STAT3 in myeloma cells, boosts drug efficacy, stunts myeloma in mice.</p>Fórmula:C19H11Cl2N5Forma y color:SolidPeso molecular:380.23Guadecitabine
CAS:<p>Guadecitabine is a second-generation DNA methyltransferases inhibitor. It is used for research on acute myeloid leukemia and myelodysplastic syndromes.</p>Fórmula:C18H24N9O10PPureza:98%Forma y color:SolidPeso molecular:557.41Aurora A/PKC-IN-1
CAS:<p>Aurora A/PKC-IN-1 inhibits AurA (IC50: 6.9 nM), PKCα (IC50: 16.9 nM), and hinders breast cancer cell growth and spread.</p>Fórmula:C16H14N6OSe2Forma y color:SolidPeso molecular:464.24PRMT5-IN-10
CAS:<p>PRMT5-IN-10 exhibits promising structure-dependent inhibitory effect on the protein methyltransferase PRMT5:MEP50 complex.</p>Fórmula:C13H17N5O4Forma y color:SolidPeso molecular:307.31DDO-2093 dihydrochloride
<p>DDO-2093 dihydrochloride: potent MLL1-WDR5 inhibitor, IC50=8.6 nM, Kd=11.6 nM, antitumor.</p>Fórmula:C29H39Cl3FN9O3Forma y color:SolidPeso molecular:687.04Depudecin
CAS:<p>Depudecin, a polyketide from Alternaria brassicicola, has an 11-carbon chain with two epoxides and six stereocenters, inhibits HDAC, and is anti-angiogenic.</p>Fórmula:C11H16O4Forma y color:SolidPeso molecular:212.24UNC0379 TFA
CAS:<p>UNC0379 TFA inhibits SETD8 (IC50: 7.3 μM), selective for 15+ methyltransferases.</p>Fórmula:C25H36F3N5O4Forma y color:SolidPeso molecular:527.589Bromodomain inhibitor-8
CAS:<p>Bromodomain inhibitor-8 is an inhibitor of BET bromodomain used to treat autoimmune and inflammatory diseases.</p>Fórmula:C26H25ClN2O3Forma y color:SolidPeso molecular:448.94F-amidine
CAS:<p>F-amidine is a bioavailable irreversible PAD4 inactivator.</p>Fórmula:C14H19FN4O2Forma y color:SolidPeso molecular:294.32JNJ-9350
CAS:<p>JNJ-9350: SMOX inhibitor (IC50 0.01 μM), PAO inhibitor (IC50 0.79 μM), for cancer research.</p>Fórmula:C25H22N6OForma y color:SolidPeso molecular:422.48CPI-455 HCl
CAS:<p>CPI-455: specific KDM5A inhibitor, IC50=10±1nM, increases H3K4me3, reduces DTPs in cancer cells.</p>Fórmula:C16H15ClN4OPureza:98%Forma y color:SolidPeso molecular:314.77ZL0454
CAS:<p>ZL0454 is an effective and selective Bromodomain-containing protein 4 inhibitors (IC50: 49 and 32 nM for BD1 and BD2).</p>Fórmula:C18H22N4O3SPureza:98%Forma y color:SolidPeso molecular:374.46S2101
CAS:<p>S2101 is a specific LSD1 histone demethylase inhibitor with an IC50 of 0.99 μM and a Ki of 0.61 μM, suitable for research into cancer and viral infections.</p>Fórmula:C16H16ClF2NOPureza:98%Forma y color:SolidPeso molecular:311.75LEM-14-1189
CAS:<p>LEM-14-1189 inhibits NSD1/2/3 (IC50: 418/111/60 μM), targets nuclear receptors, and may treat cancer and blood diseases.</p>Fórmula:C35H34N6O5S2Pureza:98.06%Forma y color:SolidPeso molecular:682.81BRD4-BD1-IN-2
CAS:<p>BRD4-BD1-IN-2: Potent, selective BRD4-BD1 inhibitor, IC50=2.51µM; 20x less active on BD2; for cardiovascular/cancer research.</p>Fórmula:C20H15Br3N4O2Pureza:99.39%Forma y color:SolidPeso molecular:583.07PI3K/HDAC-IN-1
CAS:<p>PI3K/HDAC-IN-1 is a potent PI3K and HDAC dual inhibitor(IC50s of 8.1 nM and 1.4 nM, respectively).</p>Fórmula:C22H25FN4O4Pureza:98%Forma y color:SolidPeso molecular:428.46MAT2A-IN-4
CAS:<p>MAT2A-IN-4 can be used for the cancer research that is an inhibitor of methionine adenosyltransferase 2A (MAT2A)[1].</p>Fórmula:C18H16ClN3OForma y color:SolidPeso molecular:325.79SIRT5 inhibitor 2
CAS:<p>SIRT5 inhibitor 2 (compound 49) has inhibitory activity through SIRT5-dependent deacetylation and cancer and neurodegenerative diseases.</p>Fórmula:C18H12Cl2N2O3SPureza:99.38% - 99.87%Forma y color:SolidPeso molecular:407.27MC4343
<p>MC4343, a potent dual inhibitor targeting both EZH2 and histone deacetylase, presents promising potential for cancer research applications.</p>Fórmula:C36H41N5O4Forma y color:SolidPeso molecular:607.74Furamidine dihydrochloride
CAS:<p>Furamidine dihydrochloride is a cell-permeable, selective PRMT1 inhibitor that also binds AT-rich DNA. It blocks proliferation in leukemia cell lines.</p>Fórmula:C18H18Cl2N4OPureza:98.16%Forma y color:SolidPeso molecular:377.27KD 5170
CAS:<p>KD 5170, a pan inhibitor of histone deacetylases (HDACs), demonstrates widespread antitumor activity both in vitro and in vivo [1].</p>Fórmula:C20H25N3O5S2Forma y color:SolidPeso molecular:451.561,2,3,4,5,6-Hexabromocyclohexane
CAS:<p>Inhibits JAK2 autophosphorylation; non-cytotoxic at 100μM; 1μM reduces activity by 50%, 50μM nearly abolishes it.</p>Fórmula:C6H6Br6Pureza:98%Forma y color:SolidPeso molecular:557.54Bromodomain inhibitor-9
CAS:<p>Bromodomain inhibitor-9 selectively targets BRD4-1 (Kd 12 nM), used in metabolic, inflammatory, fibrotic, and autoimmune disease studies.</p>Fórmula:C24H28N4O5SForma y color:SolidPeso molecular:484.57SYK/JAK-IN-1
CAS:<p>SYK/JAK-IN-1 is a dual SYK/JAK inhibitor with IC50 values of less than 5 nM for both SYK and JAK2.</p>Fórmula:C24H26N8O3Forma y color:SolidPeso molecular:474.52Tankyrase-IN-2
CAS:<p>Tankyrase-IN-2 is a selective, potent and orally active inhibitor of tankyrase with IC50s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively</p>Fórmula:C17H14F2N2O2Pureza:98%Forma y color:SolidPeso molecular:316.3NSC-311068
CAS:<p>NSC-311068: A selective TET1 inhibitor, reducing 5hmC and AML cell viability with high TET1.</p>Fórmula:C10H6N4O4SForma y color:SolidPeso molecular:278.24GNE-272
CAS:<p>GNE-272 is a selective inhibitor of CBP/EP300 (IC50: 0.02, 0.03, and 13 μM for CBP, EP300, and BRD4, respectively) and a selective in vivo probe for CBP/EP300.</p>Fórmula:C22H25FN6O2Forma y color:SolidPeso molecular:424.47SD-1029
CAS:<p>SD-1029 is a JAK2 inhibitor and a novel Stat3 activation inhibitor that inhibits Stat3 phosphorylation and JAK-STAT signaling.</p>Fórmula:C25H32Br2Cl2N2O3Forma y color:SolidPeso molecular:639.256(5H)-Phenanthridinone
CAS:<p>6(5H)-Phenanthridinone suppresses PARP1/2, reduces RDM4 cell growth, downregulates pro-inflammatory genes, and alleviates EAE symptoms in rats.</p>Fórmula:C13H9NOForma y color:SolidPeso molecular:195.22NCC-149
CAS:<p>NCC-149 is a HDAC8 inhibitor.</p>Fórmula:C16H14N4O2SForma y color:SolidPeso molecular:326.37MS-1020
CAS:<p>MS-1020 inhibits JAK3/STAT3, blocks active JAK3, suppresses JAK3/STAT5 signaling, and targets STAT3 in certain cells.</p>Fórmula:C21H18N2O3Pureza:98%Forma y color:SolidPeso molecular:346.38AC-93253 iodide
CAS:<p>AC-93253 iodide is a selective inhibitor of SIRT2. It significantly enhances the acetylation of tubulin p53 and histone H4.</p>Fórmula:C23H25IN2SPureza:98%Forma y color:SolidPeso molecular:488.43Jaspamycin
CAS:<p>Jaspamycin (7-CN-7-C-Ino) does not bind with purified human PKARIα.</p>Fórmula:C12H12N4O5Forma y color:SolidPeso molecular:292.25Ac-Lys-AMC
CAS:<p>Ac-Lys-AMC (Hexanamide) is a fluorescent substrate for histone deacetylase HDACs.</p>Fórmula:C18H23N3O4Pureza:98%Forma y color:SolidPeso molecular:345.39(R)-UT-155
CAS:<p>(R)-UT-155 is a selective androgen receptor degrader (SARD) ligand.</p>Fórmula:C20H15F4N3O2Forma y color:SolidPeso molecular:405.35ZYJ-34v
CAS:<p>ZYJ-34v is an oral histone deacetylase inhibitor (HDACi) with potent antitumor activities.</p>Fórmula:C27H35N3O6Pureza:98%Forma y color:SolidPeso molecular:497.58TUL01101
CAS:<p>TUL01101, a selective oral JAK1 inhibitor (IC50: 3 nM), also targets JAK2, JAK3, TYK2; for rheumatoid arthritis research.</p>Fórmula:C22H25F2N5O2Forma y color:SolidPeso molecular:429.46ARTD10/PARP10-IN-1
CAS:<p>ARTD10/PARP10-IN-1 is a PARP inhibitor that inhibits ARTD8/PARP14 and has anticancer and antitumour activity for the study of prostate cancer.</p>Fórmula:C12H12N2O4Pureza:99.14%Forma y color:SolidPeso molecular:248.23BPTF-IN-1
CAS:<p>BPTF-IN-1 (AU1), a BPTF bromodomain inhibitor with 2.8 μM affinity, shows higher selectivity over BRD4 and possesses antimalarial properties.</p>Fórmula:C23H23FN6O3Forma y color:SolidPeso molecular:450.47CPI-4203
CAS:<p>CPI-4203 is a selective inhibitor of KDM5 demethylases.</p>Fórmula:C16H14N4OForma y color:SolidPeso molecular:278.31LSD1-IN-13
CAS:<p>LSD1-IN-13, an oral LSD1 blocker (IC50: 24.43 nM), boosts CD86 (EC50: 470 nM), and triggers AML cell line differentiation.</p>Fórmula:C23H29N3O2SForma y color:SolidPeso molecular:411.56BI-9321
CAS:<p>BI-9321: Selective NSD3-PWWP1 antagonist, Kd 166 nM. Inactive against NSD2-PWWP1/NSD3-PWWP2.</p>Fórmula:C22H21FN4Pureza:98%Forma y color:SolidPeso molecular:360.43SHP2/HDAC-IN-1
CAS:<p>SHP2/HDAC-IN-1: dual SHP2/HDAC inhibitor, IC50: 20.4 nM/25.3 nM, boosts antitumor immunity, aids cancer immunotherapy research.</p>Fórmula:C34H35Cl2N7O3Forma y color:SolidPeso molecular:660.59Acefylline piperazine
CAS:<p>Acefylline piperazine, a less toxic theophylline derivative, treats asthma and bronchitis by bronchodilation, stimulating respiration and CNS.</p>Fórmula:C9H10N4O4·xC4H10N2Forma y color:SolidPeso molecular:562.54PKN1/2-IN-1
CAS:<p>PKN1/2-IN-1 is a potent and selective PKN2 inhibitor, membrane permeability and anticancer.Protein kinase N proteins (PKN) are effectors of Rho GTPases.</p>Fórmula:C14H15N3OPureza:99.72%Forma y color:SolidPeso molecular:241.29BiBET
CAS:<p>BiBET is a potent, selective, bivalent inhibitor of BET bromodomains.</p>Fórmula:C26H30N10O3Forma y color:SolidPeso molecular:530.58KDM2B-IN-3
CAS:<p>KDM2B-IN-3, from patent WO2016112284A1 as compound 183c, potently inhibits histone demethylase KDM2B, with cancer research potential.</p>Fórmula:C25H30N2O2Forma y color:SolidPeso molecular:390.52GS-626510
CAS:<p>GS-626510 is an orally bioavailable inhibitor of BET family bromodomains (Kd: 0.59-3.2 nM for BRD2/3/4; IC50: 83 nM and 78 nM for BD1 and BD2).</p>Fórmula:C25H22N4OForma y color:SolidPeso molecular:394.47AMPK activator
CAS:<p>AMPK activator</p>Fórmula:C22H21FO4Pureza:98%Forma y color:SolidPeso molecular:368.41,2-Didecanoylglycerol
CAS:<p>1,2-Didecanoylglycerol has functions as bioregulator of protein kinase C in human platelets.</p>Fórmula:C23H44O5Forma y color:SolidPeso molecular:400.59LW479
CAS:<p>LW479 is a novel inhibitor of HDAC and is a promising candidate for the prevention of breast cancer.</p>Fórmula:C21H23BrN2O4SForma y color:SolidPeso molecular:479.39NSD3-IN-1
CAS:<p>NSD3-IN-1, a histone methyltransferase NSD3 inhibitor, demonstrates an IC50 of 28.58 μM.</p>Fórmula:C13H13N5OSForma y color:SolidPeso molecular:287.34HPB
CAS:<p>HPB is a selective HDAC6 deacetylase inhibitor</p>Fórmula:C18H20N2O4Forma y color:SolidPeso molecular:328.36KDM5A-IN-1
CAS:<p>KDM5A-IN-1 is a pan-histidine lysine demethylase 5 KDM5 inhibitor that inhibits KDM5A, KDM5B, and KDM5C.Can be used in the study of cancer.</p>Fórmula:C15H22N4O2Pureza:>99.99%Forma y color:SolidPeso molecular:290.36Galegine hydrochloride
CAS:<p>Galegine hydrochloride, from G. officinalis, leads to weight loss, activates AMPK in various cells, and has antibacterial properties.</p>Fórmula:C6H14ClN3Forma y color:SolidPeso molecular:163.65DC_517
CAS:<p>DC_517 is an inhibitor of DNA methyltransferase 1 (DNMT1) ( IC50: 1.7 μM; Kd: 0.91 μM).</p>Fórmula:C33H35N3O2Forma y color:SolidPeso molecular:505.65HDAC-IN-43
CAS:<p>HDAC-IN-43: potent HDAC 1/3/6 inhibitor (IC50: 82 nM HDAC1, 45 nM HDAC3, 24 nM HDAC6); weak PI3K/mTOR (IC50: 3.6μM, 3.7μM); anti-proliferative.</p>Fórmula:C22H28N6O4Forma y color:SolidPeso molecular:440.5L 888607 Racemate
CAS:<p>L 888607 Racemate blocks DP1 and TP receptors with 132 nM and 17 nM affinity.</p>Fórmula:C19H15ClFNO2SForma y color:SolidPeso molecular:375.84Tyk2-IN-7
CAS:<p>Tyk2-IN-7 is an inhibitor of TYK2 JH2, binds to the TYK2 JH2 domain (IC50: 0.00053 μM; Ki.app: 0.00007 μM).</p>Fórmula:C18H15D3N6O3SPureza:98%Forma y color:SolidPeso molecular:401.46TK4b
CAS:<p>TK4b, a JAK inhibitor, targets leukemia/lymphoid diseases, with IC50s: 18.42 nM (JAK3) & 19.40 nM (JAK2).</p>Fórmula:C21H22N2O2Forma y color:SolidPeso molecular:334.41Pulrodemstat Methylbenzenesulfonate
CAS:<p>LSD1-IN-7 Methylbenzenesulfonate is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity.</p>Fórmula:C31H31F2N5O5SPureza:98%Forma y color:SolidPeso molecular:623.67ZIKV-IN-3
CAS:<p>ZIKV-IN-3, an andrographolide derivative, inhibits ZIKV NS5 MTase (IC50: 18.34 μM) and replication. Used for Zika virus research.</p>Fórmula:C39H41NO4Forma y color:SolidPeso molecular:587.75YM-53601 free base
CAS:<p>YM-53601 free base is an inhibitor of squalene synthetase which suppresses lipogenic biosynthesis and lipid secretion in rodents.</p>Fórmula:C21H21FN2OPureza:98%Forma y color:SolidPeso molecular:336.4EP009
CAS:<p>EP009, a novel, selective, and orally active inhibitor of JAK3, induces therapeutic response in T-cell malignancies.</p>Fórmula:C14H24O2Forma y color:SolidPeso molecular:224.34MDK8228
CAS:<p>MDK8228 is an inhibitor of CBP/p300 and BRD4 bromodomain. MDK8228 downregulates IL-6, IL-ß and IFN-ß in macrophages.</p>Fórmula:C31H41N5O3Forma y color:SolidPeso molecular:531.69NVS-BET-1
CAS:<p>NVS-BET-1 is a BET bromodomain inhibitor. NVS-BET-1 can regulate keratinocyte plasticity.</p>Fórmula:C22H21ClN4O2Forma y color:SolidPeso molecular:408.88SIRT2-IN-11
CAS:<p>SIRT2-IN-11 (AEM1), a SIRT2 inhibitor (IC50 18.5μM), induces apoptosis and affects p53, used in cancer research.</p>Fórmula:C21H22N2OForma y color:SolidPeso molecular:318.41RM65
CAS:<p>RM65 is an arginine methyltransferase inhibitor.</p>Fórmula:C34H32N2O4S2Pureza:98%Forma y color:SolidPeso molecular:596.76HIF-1α-IN-3
CAS:<p>HIF-1α-IN-3, also known as Compound (S)-3f, is a hypoxia-selective inhibitor of HIF-1α. It exhibits potent antiestrogenic activity [1].</p>Fórmula:C19H17N5O2Forma y color:SolidPeso molecular:347.37CBB1003
CAS:<p>CBB1003 is a new inhibitor of histone demethylase LSD1 (IC50: 10.54 μM).</p>Fórmula:C25H31N9O4Pureza:98%Forma y color:SolidPeso molecular:521.57PF-739
CAS:<p>PF-739 is an AMPK agonist that has been shown to activate AMPK in hepatocytes and skeletal muscle.</p>Fórmula:C23H23ClN2O5Pureza:98%Forma y color:SolidPeso molecular:442.89HDAC-IN-29
CAS:<p>HDAC-IN-29 (compound 13b) is a potent pan- HDAC inhibitor with antitumor activity.</p>Fórmula:C20H23N3O4SForma y color:SolidPeso molecular:401.48DC-BPi-03
CAS:<p>DC-BPi-03 is a potent BPTF-BRD inhibitor with an IC 50 of 698.3 nM and a K d of 2.81 μM .</p>Fórmula:C14H14N4O2SPureza:98.96%Forma y color:SolidPeso molecular:302.35Butyrolactone 3
CAS:<p>Butyrolactone 3 (MB-3) is a Gcn5 inhibitor with weak affinity for CBP.Butyrolactone 3 has antimicrobial activity and can be used in cancer.</p>Fórmula:C9H12O4Pureza:98.99% - 99.5%Forma y color:SolidPeso molecular:184.19EZH2-IN-13
CAS:<p>EZH2-IN-13 is a potent EZH2 inhibitor with potential anticancer activity.EZH2-IN-13 may be used to study diseases associated with EZH2 activity.</p>Fórmula:C34H45N5O3Pureza:98.3%Forma y color:SolidPeso molecular:571.75Butyzamide
CAS:<p>Butyzamide: oral Mpl activator, non-peptide, antagonizes TPO receptors, boosts hMpl, Ba/F3 cells, and enhances platelets in mice.</p>Fórmula:C29H32Cl2N2O5SPureza:99.51% - 99.83%Forma y color:SoildPeso molecular:591.55TNG908
CAS:<p>TNG908, a brain-penetrant PRMT5 inhibitor, is 15x more selective for MTAP mutant vs WT lines, useful in cancer studies.</p>Fórmula:C21H23N5O2SPureza:98.08% - 98.24%Forma y color:SolidPeso molecular:409.51PU139
CAS:<p>PU139 is a novel inhibitor of histone acetyltransferase (HAT).</p>Fórmula:C12H7FN2OSPureza:99.96%Forma y color:SolidPeso molecular:246.26Crebinostat
CAS:<p>Crebinostat: potent HDAC inhibitor, boosts synapsin-1 in neurons, enhances memory and gene Egr1 expression in mice.</p>Fórmula:C20H23N3O3Pureza:94.96%Forma y color:SolidPeso molecular:353.41DCPLA-ME
CAS:<p>DCPLA-ME (2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester) is the methyl ester form of DCPLA and can be used to treat neurodegenerative</p>Fórmula:C21H38O2Pureza:99.80%Forma y color:SolidPeso molecular:322.53STS-E412
CAS:<p>STS-E412 is a tissue-protective and selective EPOR/CD131 receptor activator for the study of neurological disorders.</p>Fórmula:C15H15ClN4O2Pureza:99.01%Forma y color:SolidPeso molecular:318.76Raxofelast
CAS:<p>Raxofelast (IRFI-016), a vitamin-like, hydrophilic antioxidant, mitigates ischemia-reperfusion in testis and may treat diabetic issues and atherosclerosis.</p>Fórmula:C15H18O5Pureza:99.74% - 99.97%Forma y color:SolidPeso molecular:278.3BAY-299
CAS:<p>BAY-299 inhibits BRPF2, TAF1, and TAF1L with IC50s of 67, 8, and 106 nM.</p>Fórmula:C25H23N3O4Pureza:99.53%Forma y color:SolidPeso molecular:429.47LEM-14
CAS:<p>LEM-14 is a potent NSD2-specific inhibitor (IC50:132 μM).LEM-14 may be used in the study of multiple myeloma.</p>Fórmula:C25H26N4O4SPureza:98.3%Forma y color:SolidPeso molecular:478.56CMP-5
CAS:<p>CMP-5 is a PRMT5 inhibitor with antiviral activity, inhibits PRMT5 methyltransferase activity, and can be used in the study of SARS virus infection.</p>Fórmula:C21H21N3Pureza:98.68%Forma y color:SolidPeso molecular:315.41TM2-115
CAS:<p>TM2-115 is a inhibitor of malaria parasite histone methyltransferases that results in rapid and irreversible parasite death [1].</p>Fórmula:C28H38N6O2Pureza:97.67%Forma y color:SolidPeso molecular:490.64ZEN-3219
CAS:<p>ZEN-3219 is a BET inhibitor, which has inhibitory effect on BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2).</p>Fórmula:C19H18N2O3Pureza:99.06%Forma y color:SolidPeso molecular:322.36TGP-377/421
CAS:<p>TGP-377/421 (Targapre-miR-377/421) is a potent miR-377 and miR-421 dual inhibitor that inhibits miR-377 and miR-421 by binding to their functional sites.</p>Fórmula:C20H16N6Pureza:98.48%Forma y color:SolidPeso molecular:340.38DW14800
CAS:<p>DW14800 is an inhibitor of PRMT5 (IC50 = 17 nM), enhances the transcription of HNF4α, and reduces the level of H4R3me2s.</p>Fórmula:C31H36N4O3Pureza:99.55% - 99.68%Forma y color:SolidPeso molecular:512.64Cedazuridine
CAS:<p>Cedazuridine ((4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine) is an oral inhibitor of cytidine deaminase with antineoplastic properties.</p>Fórmula:C9H14F2N2O5Pureza:99.66%Forma y color:SolidPeso molecular:268.21CEP-9722
CAS:<p>CEP-9722 is a PARP-1 and PARP-2 inhibitor with anticancer activity and is used in the study of ovarian cancer.</p>Fórmula:C24H26N4O3Pureza:98.38% - 98.56%Forma y color:SolidPeso molecular:418.49GRK6-IN-1
CAS:<p>GRK6-IN-1 (compound 18) is a potent GRK6 blocker, with an IC50 of 120 nM, showing promise for multiple myeloma research.</p>Fórmula:C22H23ClN6O2Pureza:99.37%Forma y color:SolidPeso molecular:438.91Procainamide
CAS:<p>Procainamide: DNMT1 inhibitor, Class 1A antiarrhythmic, promising for cancer and arrhythmia research.</p>Fórmula:C13H21N3OPureza:99.92% - 99.92%Forma y color:SolidPeso molecular:235.33CPUY074020
CAS:<p>CPUY074020 is a potent and orally bioavailable inhibitor of histone methyltransferase G9a (IC50: 2.18 μM) with anti-proliferative activity.</p>Fórmula:C25H28N4O2Pureza:98.64%Forma y color:SolidPeso molecular:416.52
